An extract found in cinnamon bark, called CEppt, contains properties that can delay the development of Alzheimer's disease, according to a study published in the journal PloS One.
The research team at Tel Aviv University tested CEppt on mice that were raised with five aggressive strains of Alzheimer's-inducing genes.
When given water containing a CEppt solution over four months, researchers found that the ingredient inhibited the formation of toxic amyloid plaques and also prevented these plaques from killing brain cells in the mice. Amyloid plaques are a major hallmark of Alzheimer's disease.
Alzheimer's Society comment
'This is an interesting study which looks at the benefits of a specific ingredient in cinnamon. However people shouldn't rush out to buy this popular spice. This research is in the early stages and looked at mice not humans. We are therefore a long way from using cinnamon in the fight against Alzheimer's. We need greater investment in dementia research to help us translate potential opportunities like this into effective treatments for people living with this devastating condition.'
Professor Clive Ballard
Director of Research